• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤成纤维细胞在皮肤疾病治疗中的效用:隐性营养不良型大疱性表皮松解症的范例。

The utility of dermal fibroblasts in treatment of skin disorders: A paradigm of recessive dystrophic epidermolysis bullosa.

机构信息

Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Medical Nano-Technology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Dermatol Ther. 2021 Jul;34(4):e15028. doi: 10.1111/dth.15028. Epub 2021 Jun 28.

DOI:10.1111/dth.15028
PMID:34145697
Abstract

Dermal fibroblasts are the most accessible cells in the skin that have gained significant attention in cell therapy. Applying dermal fibroblasts' regenerative capacity can introduce new patterns to develop cell-based therapies to treat skin disorders. Dermal fibroblasts originate from mesenchymal cells and are located within the dermis. These cells are mainly responsible for synthesizing glycosaminoglycans, collagens, and components of extracellular matrix supporting skin's structural integrity. Preclinical studies suggested that allogeneic and autologous dermal fibroblasts provide widespread and beneficial applications for wound healing, burn ulcers, and inherited skin disorders. In this regard, generating induced pluripotent stem cells (iPSCs) from fibroblasts and gene-edited fibroblasts are promising approaches for treating skin disorders. Here, we aimed to review literature about ongoing and completed clinical trials that applied fibroblasts and bioengineered fibroblasts as therapeutic agents for various skin disorders. This review explores cell therapy protocols from the earliest phase of allogeneic and autologous fibroblasts development in different benches to translating them into bedside-level treatment for skin disorders, particularly recessive dystrophic epidermolysis bullosa.

摘要

皮肤成纤维细胞是皮肤中最容易获取的细胞,在细胞治疗中受到了广泛关注。利用皮肤成纤维细胞的再生能力,可以为开发基于细胞的治疗方法来治疗皮肤疾病引入新的模式。皮肤成纤维细胞起源于间充质细胞,位于真皮层内。这些细胞主要负责合成糖胺聚糖、胶原和细胞外基质的成分,支持皮肤的结构完整性。临床前研究表明,同种异体和自体皮肤成纤维细胞为创伤愈合、烧伤溃疡和遗传性皮肤疾病提供了广泛而有益的应用。在这方面,从成纤维细胞和基因编辑成纤维细胞中生成诱导多能干细胞(iPSCs)是治疗皮肤疾病的有前途的方法。在这里,我们旨在回顾关于正在进行和已完成的临床试验的文献,这些试验将成纤维细胞和生物工程成纤维细胞作为治疗各种皮肤疾病的治疗剂。本综述探讨了从不同平台的同种异体和自体成纤维细胞开发的早期阶段到将其转化为皮肤疾病(特别是隐性营养不良性大疱性表皮松解症)床边治疗的细胞治疗方案。

相似文献

1
The utility of dermal fibroblasts in treatment of skin disorders: A paradigm of recessive dystrophic epidermolysis bullosa.皮肤成纤维细胞在皮肤疾病治疗中的效用:隐性营养不良型大疱性表皮松解症的范例。
Dermatol Ther. 2021 Jul;34(4):e15028. doi: 10.1111/dth.15028. Epub 2021 Jun 28.
2
Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.基因治疗:寻求恢复隐性营养不良型大疱性表皮松解症中的皮肤黏附
Exp Dermatol. 2014 Jan;23(1):1-6. doi: 10.1111/exd.12246.
3
Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs.碱基编辑器纠正隐性营养不良性大疱性表皮松解症患者来源成纤维细胞和 iPSC 中的 COL7A1 突变。
J Invest Dermatol. 2020 Feb;140(2):338-347.e5. doi: 10.1016/j.jid.2019.07.701. Epub 2019 Aug 19.
4
Gene therapy for recessive dystrophic epidermolysis bullosa.隐性营养不良型大疱性表皮松解症的基因治疗。
Dermatol Clin. 2010 Apr;28(2):361-6, xii. doi: 10.1016/j.det.2010.02.003.
5
Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.基因矫正 iPS 细胞作为隐性营养不良型大疱性表皮松解症的细胞治疗方法。
Sci Transl Med. 2014 Nov 26;6(264):264ra165. doi: 10.1126/scitranslmed.3010083.
6
Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.正常的和经基因校正的营养不良性大疱性表皮松解症成纤维细胞自身就能在基底膜区产生VII型胶原蛋白。
J Invest Dermatol. 2003 Nov;121(5):1021-8. doi: 10.1046/j.1523-1747.2003.12571.x.
7
A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.一项用于隐性营养不良型大疱性表皮松解症的皮内同种异体成纤维细胞的 II 期随机对照试验。
J Am Acad Dermatol. 2013 Dec;69(6):898-908.e7. doi: 10.1016/j.jaad.2013.08.014. Epub 2013 Sep 24.
8
Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.使用自失活COL7A1逆转录病毒载体的基因校正成纤维细胞疗法治疗隐性营养不良性大疱性表皮松解症
J Invest Dermatol. 2016 Jul;136(7):1346-1354. doi: 10.1016/j.jid.2016.02.811. Epub 2016 Mar 16.
9
Response of intractable skin ulcers in recessive dystrophic epidermolysis bullosa patients to an allogeneic cultured dermal substitute.隐性营养不良型大疱性表皮松解症患者难治性皮肤溃疡对同种异体培养真皮替代物的反应。
Acta Derm Venereol. 2010 Mar;90(2):165-9. doi: 10.2340/00015555-0776.
10
Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.隐性营养不良性大疱性表皮松解症中的回复性嵌合成纤维细胞
Br J Dermatol. 2019 Dec;181(6):1247-1253. doi: 10.1111/bjd.17943. Epub 2019 Jul 8.

引用本文的文献

1
Reprogramming stem cells in regenerative medicine.再生医学中的干细胞重编程。
Smart Med. 2022 Dec 25;1(1):e20220005. doi: 10.1002/SMMD.20220005. eCollection 2022 Dec.
2
Treatment of Epidermolysis Bullosa and Future Directions: A Review.大疱性表皮松解症的治疗及未来方向:综述
Dermatol Ther (Heidelb). 2024 Aug;14(8):2059-2075. doi: 10.1007/s13555-024-01227-8. Epub 2024 Aug 2.
3
Highly efficient CRISPR/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa.高效的CRISPR/Cas9介导的外显子跳跃用于隐性营养不良性大疱性表皮松解症。
Bioeng Transl Med. 2024 Jan 17;9(4):e10640. doi: 10.1002/btm2.10640. eCollection 2024 Jul.
4
[Cell therapy and wound repair].[细胞疗法与伤口修复]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024 Mar 20;40(3):221-229. doi: 10.3760/cma.j.cn501225-20240108-00009.
5
Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa.基因编辑细胞:用于大疱性表皮松解症的新型异基因基因/细胞疗法。
J Appl Genet. 2024 Dec;65(4):705-726. doi: 10.1007/s13353-024-00839-2. Epub 2024 Mar 9.
6
Overexpression of VEGF in dermal fibroblast cells accelerates the angiogenesis and wound healing function: in vitro and in vivo studies.真皮成纤维细胞中 VEGF 的过表达可加速血管生成和伤口愈合功能:体外和体内研究。
Sci Rep. 2022 Nov 2;12(1):18529. doi: 10.1038/s41598-022-23304-8.
7
Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds.大疱性表皮松解症:用于治疗创面的组织工程皮肤替代物的综述。
Mol Diagn Ther. 2022 Nov;26(6):627-643. doi: 10.1007/s40291-022-00613-2. Epub 2022 Oct 17.
8
Stem Cell Technology and Skin Disorders: from Stem Cell Biology to Clinical Applications.干细胞技术与皮肤疾病:从干细胞生物学到临床应用
Stem Cell Rev Rep. 2022 Aug;18(6):1881-1882. doi: 10.1007/s12015-022-10381-5. Epub 2022 Jul 26.
9
Genetic Disorders of the Extracellular Matrix: From Cell and Gene Therapy to Future Applications in Regenerative Medicine.细胞外基质的遗传疾病:从细胞和基因治疗到再生医学的未来应用
Annu Rev Genomics Hum Genet. 2022 Aug 31;23:193-222. doi: 10.1146/annurev-genom-083117-021702. Epub 2022 May 10.